RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis

Ho Yin Edwin Chan1

  • 1Laboratory of Drosophila Research, School of Life Sciences, Faculty of Science, The Chinese University of Hong Kong Hong Kong, China ; Biochemistry Programme, School of Life Sciences, Faculty of Science, The Chinese University of Hong Kong Hong Kong, China.

Insights

RNA toxicity pathways contribute to human diseases. This review details common RNA toxicity mechanisms, including epigenetic silencing and repeat expansion disorders like polyglutamine diseases.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Gene transcription generates diverse ribonucleic acid (RNA) species with critical cellular functions.
  • Emerging research highlights RNA-mediated toxicity pathways in various human pathologies.
  • Understanding these pathways is crucial for disease mechanism elucidation.

Purpose of the Study:

  • To review and describe common RNA toxicity pathways.
  • To emphasize RNA toxicity mechanisms involving nucleotide repeat expansion.
  • To connect these mechanisms to specific human disorders.

Main Methods:

  • Literature review of RNA toxicity pathways.
  • Categorization of common RNA toxicity mechanisms.
  • Focus on nucleotide repeat expansion-associated toxicity.

Main Results:

  • Identified key RNA toxicity pathways: epigenetic gene silencing, nucleolar stress, nucleocytoplasmic transport, bi-directional gene transcription, repeat-associated non-ATG translation, RNA foci formation, and cellular protein sequestration.
  • Highlighted mechanisms involving nucleotide repeat expansion.
  • Linked these mechanisms to polyglutamine disorders and frontotemporal lobar degeneration-amyotrophic lateral sclerosis.

Conclusions:

  • RNA toxicity pathways represent a significant pathogenic mechanism in human diseases.
  • Nucleotide repeat expansions are a critical driver of RNA toxicity in specific neurological disorders.
  • Further research into RNA toxicity is essential for therapeutic development.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Amyloid Fibrils03:03

Amyloid Fibrils

7.0K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
4
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
12.2K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
9.4K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
1